Clinical trial · Interventional
Golf Recreational Exercise for Enhanced Survivorship in Prostate Cancer Survivors
Golf Recreational Exercise for Enhanced Survivorship in Prostate Cancer Survivors Undergoing Hormone Therapy (GREENS)
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This clinical trial evaluates a golf recreational exercise program for enhancing survivorship in underrepresented prostate cancer survivors. Golf is a multimodal recreational activity that requires participants to utilize all muscle groups to perform the golf swing, walk over hilly and uneven terrain, maintain balance during putting and squat-like tasks. Physical activity and exercise are beneficial to physical function, cognitive function, psychosocial health, and overall quality of life during prostate cancer survivorship. These aspects of health are impacted by prostate cancer treatment, especially androgen deprivation therapy. Additionally, supervised, group-based activity programs facilitate participation in physical activity. Researchers want to examine the changes in functional abilities, psychosocial health, and quality of life following participation in in a golf program designed for prostate cancer survivors.
Conditions
Conditions (5)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Localized Prostate Carcinoma | Prostate Carcinoma | CURATED_BROADER | 0.78 |
| Locally Advanced Prostate Carcinoma | Prostate Carcinoma | CURATED_BROADER | 0.78 |
| Stage III Prostate Cancer AJCC v8 | Malignant Prostate Neoplasm | CURATED_BROADER | 0.78 |
| Stage II Prostate Cancer AJCC v8 | Malignant Prostate Neoplasm | CURATED_BROADER | 0.78 |
| Stage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8 | — | UNRESOLVED | — |
Interventions
Interventions (9)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Biospecimen Collection | Procedure | — | UNRESOLVED |
| Discussion | Procedure | — | UNRESOLVED |
| Exercise Intervention | Other | — | UNRESOLVED |
| Interview | Other | — | UNRESOLVED |
| Medical Device Usage and Evaluation | Other | — | UNRESOLVED |
| Physical Examination | Procedure | — | UNRESOLVED |
| Physical Performance Testing | Other | — | UNRESOLVED |
| Questionnaire Administration | Other | — | UNRESOLVED |
| Recreational Therapy |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Supportive care (golf program)
- description
- Patients participate in the golf training program composed of group sessions over 1-2 hours with a PGA professional two times per week for ten weeks. Training consists of complimentary/warm up exercises integrated with pelvic floor muscle training, golf instruction, golf practice, and golf play on a Par 3 public golf course. Patients also wear an activity tracker and undergo blood sample collection on the study.
- interventionNames
- Procedure: Biospecimen Collection
- Procedure: Discussion
- Other: Exercise Intervention
- Other: Interview
- Other: Medical Device Usage and Evaluation
- Procedure: Physical Examination
- Other: Physical Performance Testing
- Other: Questionnaire Administration
- Other: Recreational Therapy
Primary outcomes (13)
- measure
- Enrollment rate
- timeFrame
- Up to 3 years
- description
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 55 Years
- Maximum age
- 85 Years
Show eligibility criteria text
Inclusion Criteria: * First time, primary diagnosis of prostate cancer (PCa) * Currently receiving androgen deprivation therapy (ADT) and/or androgen receptor blocker) for more than 6 months * Older adult male: 55-85 years old * The ability to stand independently without external support * No or minimal golf experience (played \< 5 times in the past 10 years) * English speaking Exclusion Criteria: * Second cancer diagnosis (excluding non-invasive skin cancers) or bone metastases * Prostatectomy less than 6 months prior to study enrollment (prostatectomy is not a requirement for study entry) * Symptomatic cardiovascular disease, active angina, uncontrolled hypertension (systolic blood pressure (SBP) \> 160 or diastolic blood pressure (DBP) \> 90, high resting pulse heart rate (HR) \> 90), symptomatic orthostatic hypotension * Unstable asthma, exacerbated chronic obstructive pulmonary disease (COPD\] * History of injury or orthopedic operation within the last 6 months * Movement disorders (e.g., Parkinson's disease (PD) or other neurological disorders), hemiparesis or paraparesis * Severe vision or hearing problems
References
Publications (0)
Data not yet available